summary
Introduced
02/06/2025
02/06/2025
In Committee
03/21/2025
03/21/2025
Crossed Over
Passed
Dead
Introduced Session
104th General Assembly
Bill Summary
Creates the Canadian Prescription Drug Importation Act. Provides that the Department of Public Health shall establish the Canadian prescription drug importation program for the importation of safe and effective prescription drugs from Canada which have the highest potential for cost savings to the State. Provides that the Department shall contract with a vendor to provide services under the program. Provides that by December 1, 2026 and each year thereafter, the vendor shall develop a wholesale prescription drug importation list identifying the prescription drugs that have the highest potential for cost savings to the State. Provides that the vendor shall identify Canadian suppliers that are in full compliance with the provisions of the Act and contract with the Canadian suppliers to import drugs under the program. Provides for: a bond requirement; requirements for eligible prescription drugs; requirements for eligible Canadian suppliers; requirements for eligible importers; distribution requirements; federal approval; prescription drug supply chain documentation; immediate suspension of specified imported drug; requirements of an annual report; notification of federal approval. Provides that the Department shall adopt rules necessary to implement the Act. Effective immediately.
AI Summary
This bill creates the Canadian Prescription Drug Importation Act, which establishes a program allowing the importation of prescription drugs from Canada to help reduce drug costs for Illinois residents. The bill recognizes that U.S. consumers pay significantly higher prices for prescription drugs compared to Canadian consumers and seeks to leverage Canada's robust drug regulatory system to provide more affordable medications. Key provisions include creating a program within the Department of Public Health that will contract with vendors to identify and import prescription drugs with the highest potential for cost savings. The program has strict requirements for eligible drugs, Canadian suppliers, and importers, including safety testing, compliance with federal regulations, and restrictions on which types of drugs can be imported. Eligible importers are limited to Medicaid pharmacies, the Department of Corrections, commercial plans, and licensed pharmacists or wholesalers. The bill requires federal approval before implementation, mandates annual reporting on the program's performance, and includes provisions for ensuring drug safety, such as testing each imported drug batch for authenticity and quality. To participate, Canadian suppliers must be fully compliant with Canadian laws and have a registered U.S. agent, and importers are prohibited from distributing imported drugs outside of Illinois. The ultimate goal is to provide a safe mechanism for reducing prescription drug costs while maintaining rigorous safety standards.
Committee Categories
Budget and Finance
Sponsors (1)
Last Action
Rule 19(a) / Re-referred to Rules Committee (on 03/21/2025)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.ilga.gov/legislation/BillStatus.asp?DocNum=3134&GAID=18&DocTypeID=HB&SessionID=114&GA=104 |
| BillText | https://www.ilga.gov/legislation/104/HB/10400HB3134.htm |
Loading...